SUMMARY To determine whether symptoms of gastro-oesophageal reflux are related to the degree of oesophageal acid exposure, 190 patients (of 220 referred) with heartburn and acid regurgitation were compared with 50 normal subjects. A definite relationship between frequency of reflux symptoms and degree of oesophageal acid exposure was found both in patients with and without oesophagitis. We conclude that the frequency of gastro-oesophageal reflux symptoms is related to degree of oesophageal acid exposure.
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Dyspepsia is a condition mainly characterised by the lack of a distinct definition.' Symptoms vary from mild flatulence to severe epigastric pain and may be caused by colonic dysmotility, gall stones, peptic ulcer, cancer and oesophagitis. Dyspepsia is a common complaint and often treated without further investigation. An attempt was recently made to analyse dyspeptic symptoms into more distinct subgroups in order to give better guidelines for treatment.' One subgroup suggested was 'gastrooesophageal reflux-like dyspepsia' mainly characterised by ' Patients with frequent symptoms exhibited significantly higher acid exposure of the oesophagus than those with less frequent symptoms, though even the latter suffered from significantly higher median acid exposure than asymptomatic subjects (Table) . All study groups showed the typical distribution of acid reflux during the 24 hours of pH monitoring but on clearly different levels. While little reflux was detected during the 'sleep hours' from midnight to six am, the acid exposure increased during the day with a peak in late afternoon and evening. Patients with almost continuous symptoms already had a high acid exposure in the morning (Figure) .
Discussion
This study suggests that if a patient presents with reflux-like dyspepsia, there is a considerable chance that the acid exposure of the mucosa in the distal oesophagus is increased in comparison with asymptomatic subjects. The more frequent the symptoms, the greater the acid exposure. This is true for patients with and without macroscopic signs of erosive oesophagitis.
Increased acid exposure of the distal oesophageal mucosa may lead to symptoms of reflux such as heartburn and acid regurgitation. Depending on reflux intensity, clearance capacity, mucosal resistance and composition of the refluxed material erosive changes gradually may develop. This process is asylnptomatic endoscopicallY normal subjects.
known as gastro-oesophageal reflux (GOR) which may be present both with and without macroscopic oesophagitis. When a patient with GOR seeks medical advice, he has usually tried proprietary antacid or alginic acid compounds and is not satisfied with their effect. The increased oesophageal acid exposure in these patients indicates that efficient acid reducing antireflux therapy should be instituted in adjunct to general antireflux advice. The logic of this attitude was confirmed in a study of cimetidine for treatment of non-ulcer dyspepsia. Patients responding best were those with reflux symptoms. 4 The question remaining is one of dosing regime. Acid exposure after midnight is low, indicating against bed time medication. In patients with less severe symptoms, it seems logical to concentrate the acid reduction to afternoon and evening -for example, prescribing medication at lunch and evening meals. In patients with almost constant heartburn the whole day should be covered, starting with medication at breakfast. In a few patients with night symptoms, bed time medication may be considered.
In most patients with reflux-like dyspepsia, treatment must be instituted without further investigation. Resources are usually not sufficient to obtain upper endoscopy and pH monitoring in all patients who present with reflux-like symptoms. Should, however, symptoms persist or be insufficiently controlled by medication it is advisable to send the patient for an upper endoscopy. Many patients, however, with increased acid exposure do not show signs of macroscopic oesophagitis, even if symptoms are severe: In these patients an intraoesophageal pH monitoring is of value. During this investigation the acid reflux profile may be determined as well as the temporal relationship between symptoms and recorded reflux episodes. In a few patients it may even be advisable to repeat the pH monitoring if normal results are obtained during the first investigation, as reflux may vary considerably from day to day. ' Treatment for GOR traditionally has been focused on healing of macroscopic oesophagitis. In our opinion symptoms are equally or, at least to the patient, more important to treat. The goal is rapid relief of symptoms; restitution of the oesophageal mucosa is a secondary benefit that in many patients will be achieved only after longterm treatment. It is important to note that disappearance of macroscopic oesophagitis in the patient with an impaired antireflux mechanism does not indicate that the patient is cured. The reflux will continue and supportive treatment will be needed for years, if not for life.
In conclusion, our study shows that reflux-like dyspepsia is accompanied by increased acid exposure of the distal oesophageal mucosa. This finding supports the view that identification of these symptoms within the heterogeneous group of dyspeptic patients serves a practical purpose with regard to their treatment.' Institution of effective acid secretory reducing medication seems to be a logical approach in patients with dyspepsia of the reflux type.
